Table of Pharmacogenomic Biomarkers in Drug Labeling

http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm 

 

Please note that this U.S. Food and Drug Administration site (of the U.S. Dept. of Health and Human Services) includes no information on sources, speed and costs of testing referenced.  Presumably psychiatrists know where to obtain this.

 

The drugs from the above website are included below because they were identified as being for the therapeutic field of psychiatry.   Initial list is from May 2015.  Drugs added to a line are from January 2016 listing.  The online table also lists the genomic biomarker for each.

 

Amitriptyline

Aripiprazole

Atomoxetine

Citalopram (1)

Citalopram (2)

Clomipramine

Clozapine    Desipramine

Diazepam

Doxepin (1)

Doxepin (2)

Fluvoxamine    Fluoxetine

Iloperidone    Imipramine, Modafinil

Nefazodone     Nortriptyline

Paroxetine      Perphenazine

Pimozide    Protriptyline

Risperidone    Thiroidazine

Trimipramine    Venlafaxine